Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E.coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.
from Top Technology News -- ScienceDaily http://bit.ly/2Ry6iud
from Top Technology News -- ScienceDaily http://bit.ly/2Ry6iud
Comments
Post a Comment